⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of FP Clinical Pharma S.R.L. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
FP Clinical Pharma S.R.L.
↗Buenos Aires, Argentina
FP Clinical Pharma is a specialized Clinical Research Organization (CRO) based in Argentina, recognized for its exclusive focus on pharmacokinetic, bioavailability, and bioequivalence studies. Since its founding in 2003, the company has provided comprehensive clinical, pharmacological, regulatory, bioanalytical, and statistical services to the local and international biopharmaceutical industry.
The company operates specialized research units, including clinical, bioanalytical, and statistical facilities, which are authorized by the Argentine Ministry of Health (ANMAT) and the Chilean Institute of Public Health (ISP). With a track record of over 350 research projects and 125 molecules studied, FP Clinical Pharma is a key partner for generic drug development and Phase I-IV clinical trials in the LATAM region.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2003
Ownership:private
Status:operating
PIPELINE
Stage:Phase 4
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:DNDi (Drugs for Neglected Diseases initiative), Laboratorios Richmond, Elea, Fundación Mundo Sano
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Ethel Feleder - Director
Martín Soler - Manager
Gustavo Yerino - Principal Investigator / Pharmacovigilance Coordinator
Scientific Founders:Martha Propker
LINKS
Website:fpclinicalpharma.com.ar
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with FP Clinical Pharma S.R.L.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.